| Topic | Key points for functional annotation | Representative evidence (paper + year + main method/result) | URL | Citation id placeholders |
|---|---|---|---|---|
| Identity | Human **SRP19** corresponds to **signal recognition particle 19 kDa protein**, a canonical eukaryotic SRP subunit in the **S domain** of the SRP ribonucleoprotein; distinct from bacterial systems that lack a true SRP19 counterpart. | **Althoff et al., 1994, NAR**: comparative/evolutionary analysis placed SRP19 among small mammalian SRP proteins and noted lack of a bacterial counterpart with equivalent binding behavior; **Faoro & Ataide, 2021**: review defines mammalian SRP as 7SL RNA plus SRP9/14/19/54/68/72. | https://doi.org/10.1093/nar/22.11.1933 ; https://doi.org/10.3389/fmolb.2021.679584 | (pqac-00000003, pqac-00000004, pqac-00000001) |
| Domains | SRP19 is a **single-domain RNA-binding protein** of the **αβ fold / βαββα topology**; functionally specialized for 7SL RNA recognition rather than enzymatic catalysis. | **Faoro & Ataide, 2021**: summarizes structural class and fold of SRP19 from prior structural work, emphasizing RNA-binding architecture. | https://doi.org/10.3389/fmolb.2021.679584 | (pqac-00000001, pqac-00000011) |
| Complex membership | SRP19 is one of the **six protein subunits** of mammalian SRP and resides in the **S domain** with **SRP54, SRP68, SRP72** on the **7SL RNA** scaffold. | **Issa et al., 2024**: defines core mammalian SRP composition and studies tagged SRP19 in SRP biogenesis; **Kellogg 2023**: places SRP19 in the S domain assembled on 7SL RNA. | https://doi.org/10.26508/lsa.202402614 | (pqac-00000002, pqac-00000010, pqac-00000006) |
| Molecular function | Primary function is **RNA-structure remodeling during SRP assembly**: SRP19 binds the **GGAG tetraloop of helix 6** in 7SL RNA, **clamps helices 6 and 8**, and induces the **closed S-domain conformation** needed for productive SRP formation. | **Oubridge et al., 2002, Mol Cell**: crystal structure of SRP19–S-domain RNA complex showed SRP19 clamps tetraloops of helices 6 and 8 and preorganizes the SRP54-binding site; **Faoro & Ataide, 2021**: review summarizes this RNA-binding mechanism. | https://doi.org/10.1016/S1097-2765(02)00530-0 ; https://doi.org/10.3389/fmolb.2021.679584 | (pqac-00000000, pqac-00000011) |
| Assembly role | SRP19 is **essential for eukaryotic SRP assembly** because **human SRP54 cannot bind 7SL RNA efficiently before SRP19 binds**; thus SRP19 acts as an upstream assembly factor within the mature complex. | **Oubridge et al., 2002**: structural/biochemical interpretation explicitly states prior SRP19 binding is required for human SRP54 incorporation; **Kellogg 2023**: depletion predicted to alter the SRP54 interface and compromise SRP integrity. | https://doi.org/10.1016/S1097-2765(02)00530-0 | (pqac-00000000, pqac-00000005, pqac-00000009) |
| Pathway context | SRP19 participates in the **co-translational protein-targeting pathway** to the **ER**, indirectly enabling signal-sequence recognition and SRP receptor engagement by building the correct S-domain architecture. It is **not an enzyme** and does **not transport substrate directly**; its role is structural/assembly-related in the SRP pathway. | **Faoro & Ataide, 2021**: reviews S-domain function in signal-sequence recognition and receptor interaction; **Kellogg 2023**: SRP co-translationally targets secretory/membrane proteins to ER and protects some mRNAs from degradation. | https://doi.org/10.3389/fmolb.2021.679584 | (pqac-00000011, pqac-00000010) |
| Localization / biogenesis route | SRP19 is synthesized in the cytoplasm, imported to the nucleus, and assembles with **7SL RNA first in the nucleolus**; pre-SRP is then exported, with final maturation completed in the cytoplasm. Mature SRP functions in the cytosol on translating ribosomes targeting to the **ER membrane**. | **Kellogg 2023**: review/preprint describes SRP19 nuclear import and first nucleolar assembly step with 7SL RNA; **Issa et al., 2024**: microscopy/proteomics show GFP-SRP19 nucleolar accumulation and dependence on nucleolar integrity. | https://doi.org/10.26508/lsa.202402614 | (pqac-00000010, pqac-00000008, pqac-00000002) |
| Recent 2024 development: nucleolar phase | New evidence strengthens the model that **SRP biogenesis partly occurs in the nucleolus** and that SRP19 transiently accumulates there; nucleolar disruption alters SRP19 localization, supporting a bona fide nucleolar assembly phase. | **Issa et al., 2024**: inducible GFP-SRP19 U2OS cell lines, quantitative proteomics, IP/WB, and perturbations (low-dose actinomycin D; uL18 depletion) demonstrated nucleolar accumulation and relocalization of SRP19 when nucleolar structure/function is perturbed. | https://doi.org/10.26508/lsa.202402614 | (pqac-00000008, pqac-00000013, pqac-00000017) |
| Recent 2023 development: SRP homeostasis | SRP19 abundance depends on other SRP subunits; loss of partner subunits reduces SRP19 protein and disrupts SRP–ribosome association, indicating coordinated SRP quality control/homeostasis. | **Kellogg 2023**: HeLa-cell work reports SRP19 and SRP54 protein attenuation after loss of other SRP subunits and disrupted ribosome association involving SRP19 in SRP54-depleted cells. | https://doi.org/10.3389/fgene.2022.898083 | (pqac-00000009) |
| Disease links: autoimmunity | SRP19 is a recognized **autoantigen** in **immune-mediated necrotizing myopathy (IMNM)** / anti-SRP myositis; anti-SRP19 antibodies are reported among the pathogenic anti-SRP specificities. | **Kellogg et al., 2022**: review lists anti-SRP19 among four SRP-targeted antibodies associated with necrotizing myopathy; **Julien et al., 2024** and **Kellogg 2023** further discuss anti-SRP antibodies in IMNM. | https://doi.org/10.3389/fgene.2022.898083 ; https://doi.org/10.3390/antib13010012 | (pqac-00000012, pqac-00000006, pqac-00000005) |
| Disease links: other human relevance | SRP19 has been implicated in **cancer-related biology** and may be perturbed in infection-related ER remodeling; these are secondary/noncanonical associations compared with its canonical SRP assembly role. | **Kellogg et al., 2022**: review notes SRP19 with SRP54/SRP68 can attenuate p53 in cervical cancer; **Wong et al., 2024** reports viral NS4B interaction with SRP19 during flaviviral ER-specific remodeling (host-pathway rewiring rather than core SRP19 function). | https://doi.org/10.3389/fgene.2022.898083 ; https://doi.org/10.1371/journal.ppat.1012766 | (pqac-00000012, pqac-00000007) |
| Quantitative stats | Recent literature provides several useful quantitative anchors: anti-SRP antibodies occur in **17–45%** of IMNM patients; idiopathic inflammatory myopathy incidence is about **2 per 100,000**; SRP dependency has been assigned to **~500 genes** by DeepRNAseq; Issa et al. report SRP19 interactome validation using **SILAC** and microscopy-based counting of Cajal body association. | **Kellogg et al., 2022**: prevalence/incidence figures for IMNM/IIM; **Kellogg 2023**: ~500 SRP-dependent genes; **Issa et al., 2024**: SILAC-based interactome and microscopy quantification of SRP19-positive nuclear bodies. | https://doi.org/10.3389/fgene.2022.898083 ; https://doi.org/10.26508/lsa.202402614 | (pqac-00000012, pqac-00000009, pqac-00000008, pqac-00000013) |


*Table: This table summarizes the identity, function, assembly role, localization, disease links, and recent developments for human SRP19 (UniProt P09132). It is designed as a compact evidence map for functional annotation, with representative sources and citation placeholders tied to available context IDs.*